Showing results (181-190 of 499) with videos related to
Sort By:
Pageof 50
Alzheimer'S Research & Therapy|October 10, 2022
Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patientsJan Traub, Markus Otto, Roxane Sell, et al.Frontiers in Neuroscience|March 23, 2017
Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI StudyKarsten Mueller, Robert Jech, Cecilia Bonnet, et al.Dementia and Geriatric Cognitive Disorders|April 2, 2005
Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseLukas Cepek, Petra Steinacker, Brit Mollenhauer, et al.Plos One|October 23, 2019
Liver transplantation in patients with a history of migration-A German single center comparative analysisJulian Nikolaus Bucher, Maximilian Koenig, Markus Bo Schoenberg, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 28, 2018
Story of the ALS-FTD continuum retold: rather two distinct entitiesDorothée E Lulé, Helena E A Aho-Özhan, Cynthia Vázquez, et al.Plos One|August 12, 2010
The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS)Johannes Brettschneider, Anne Czerwoniak, Makbule Senel, et al.International Journal of Molecular Sciences|February 26, 2022
Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt-Jakob DiseaseSamir Abu-Rumeileh, Peggy Barschke, Patrick Oeckl, et al.Dementia and Geriatric Cognitive Disorders|January 8, 2005
Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodiesBrit Mollenhauer, Lukas Cepek, Mirko Bibl, et al.Brain : a Journal of Neurology|April 8, 2006
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementiaMirko Bibl, Brit Mollenhauer, Hermann Esselmann, et al.Alzheimer'S Research & Therapy|November 24, 2022
Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer's and other neurodegenerative diseasesSteffen Halbgebauer, Petra Steinacker, Daniel Riedel, et al.Pageof 50